INTRODUCTION
Early cancer detection and improved treatments have resulted in increased survival rates over the last few decades. [1] However, declining quality of life (QOL) and increased fatigue remains a major concern in cancer patients. [2, 3] Cancer-related fatigue is defined by the National Comprehensive Cancer Network (NCCN) as "a persistent, subjective sense of tiredness related to cancer or cancer treatment that interferes with usual functioning, can be described in terms of perceived energy, mental capacity, and psychological status". [4] Persistent fatigue is recognized as one of the most common, ongoing symptoms reported by patients following cancer treatment namely radiation and chemotherapy. It is known to have profound effects on the quality of life. [5] Fatigue can be the initial manifestation of cancer and may be present before any treatment is initiated and gets aggravated during radiotherapy and chemotherapy. [6] Radiation therapy forms an integral part of management of a cancer patient. Generally about 80% of cancer patients require radiation at some point of time either in the form of radical, adjuvant or palliative intent. The radiation treatment is delivered over a period of several weeks in which invariably normal tissues are also irradiated. These result in side effects impairing the nutrition, general condition of the patient and add up to the fatigue already present. [5] Fatigue prevalence increases over the course of radiotherapy. [7] Unlike simple tiredness or situational fatigue, it is more debilitating and severe; less likely to be relieved by simple rest; and may lead to withdrawal from meaningful and enjoyable activities and may even lead to discontinuation of treatment. [8] Despite all these, there are only few studies that have quantified the impact of fatigue on overall quality of life (QOL) in cancer patients. The aim of this study is to evaluate the magnitude of fatigue in cancer patients receiving radiotherapy and its relative impact on different QOL domains/subscales.
Magnitude of fatigue in cancer patients receiving radiotherapy and its short term effect on quality of life

METHODS AND METHODS
The study was carried out from March 2004 to September 2005, on patients with histologically proven cancer receiving radiotherapy in our department. Age more than fifteen years and KPS of 70 or more were the inclusion criteria. Patients who received chemotherapy in the previous six months were excluded from the study. Patients with post-op (53.3%), radical (21.1%), palliative (24.4%) and pre-op (1.1%) intent where taken into the study. Radiation dose varied from 3000cGy to 7000cGy in 10 to 35 fractions depending on the site and intent of treatment. Ninety patients fulfilled these criteria and were included in the study. The patients' characteristics are shown in Table 1 . Fatigue and quality of life were assessed using Brief Fatigue Inventory Scale and EORTC QOL C30 questionnaire respectively. All the patients were asked to fill the questionnaires, once before start of treatment, then every week during the course of treatment and one month post treatment. Patients, who did not know to read and write, were explained about the questionnaire in their mother tongue and response was noted by the person interviewing. For the scoring of Fatigue in the brief fatigue inventory scale, the average score was taken from Q1, Q2 and Q3. The score ranged from 0 -10, where 0 represented "no fatigue" and 10 denoted "as bad as you can imagine". The quality of life was scored using EORTC QOL C30 scoring manual version 3.0. According to the parameter studied different formulae were used for calculating. All the scores were measured in the 0 to 100 scale. A high scale score represents a higher response level. Thus a high score for a functional scale represents a high/ Healthy level of functioning. A high score for the global health status represents a low QOL and a high score for the financial difficulty represents no financial difficulty.
Statistical analysis
The data collected was tabulated using Microsoft Excel work sheet and the data was analyzed using SPSS 11.0 and Sysstat 8.0. Trimean was calculated for all the parameters of QOL. The trimean is a good measure of central tendency. It is computed by adding the 25 th percentile plus twice the 50 th percentile plus the 75 th percentile and dividing by four. The trimean is almost as resistant to extreme scores as the median and is less subject to sampling fluctuations than the arithmetic mean in extremely skewed distributions. The significance was obtained by Wilcoxon Signed rank test between first week and one month post treatment. 'P' values for the difference of percentage was computed using on-line Java -Script tests on difference in two proportions estimates from a single population, based on a set of random paired observations for all the study parameters.
RESULTS
Ninety patients participated in the study. The fatigue distribution among the patients is shown in Table 2 and Figure  1 . Majority of patients during the start of treatment had mild (52/90, 57.8%) and moderate (24/90, 26.7%) degree of fatigue. Severe degree of fatigue was noted in 3.3% (3/90); however 12.2% (11/90) had no fatigue at the start of treatment. During Janaki, et al.: Fatigue during radiotherapy 
DISCUSSION
The term Fatigue has roots in several disciplines. To the physiologist, fatigue is considered a decrease in the capacity to perform work; a pathologist may view it as an indicator of a neuromuscular or metabolic disorder, and to the psychologist a symptom of depression associated with decreased motivation to engage in the mental and physical activities. [9] Fatigue in oncology is unique. Unlike acute fatigue, in which tiredness comes on quickly, lasts a short time, and is relieved by rest, cancer fatigue is prolonged, debilitating, that is persistent or recurring. [10] Various definitions of cancer related fatigue have been given till date, like the National Comprehensive Cancer Network, [4] International Classification of Disease 10th revision (ICD-10), [10] Medical Subject Headings, [11] Marcello et al, [12] suggesting that its definition as well as understanding is very difficult.
Fatigue can be either regarded as a symptom of the underlying disease (both upon presentation and in the course of relapses) or as a side effect of treatments, or as a sign of a concomitant condition. [12] In relation to the kind of therapy instituted and the type of tumor, fatigue has very specific phenomena and differs not only from fatigue in healthy people, but also from fatigue in people suffering from other diseases. [13] Fatigue is one of the most common QOL-related symptoms in cancer today. [14] For patients and oncologists, improving the QOL of cancer patients requires a heightened awareness of fatigue, a better understanding of its impact, improved communication and familiarity with interventions that can † follow up at one month after completion of treatment. *significant P value when compared to week 1 reduce its debilitating effects. [15] Almost every patient suffers from fatigue during cancer treatment and in the scientific literature reported prevalence rates of fatigue are up to 99%. [16] Following completion of therapy, cross-sectional studies involving cancer patients with different stages of disease, indicate that over 75% of patients have significant ongoing symptoms of fatigue. [17] Application of the diagnostic criteria for cancer-related fatigue (CRF) indicates that between 14 and 30% of patients have ongoing CRF with associated disability when surveyed 1-5 years after completion of treatment, [18] well in excess of the rates in the general population. [19] Research shows that chronic fatigue is associated with problems and limitations in different areas of life.
Severe fatigue leads not only to physical restrictions but also to serious impairment in QOL, social activities and the ability to go to work. [16, 20] Gregory et al from the fatigue coalition group reported that fatigue prevented patients from leading a normal life and conducting their daily routine. The patients with low physical performance levels were more depressed, anxious and socially insecure. In addition, pain or depression was more likely to occur in patients experiencing fatigue on a daily basis than those experiencing it less frequently. The mental/emotional effects of fatigue reported in ≥30% of patients. Most patients reported a need to push themselves to do things (77%), decreased motivation or interest (62%) and feelings of sadness, frustration, or irritability (53%) during their experiences with fatigue. In addition, fatigue affected typical cognitive tasks, such as concentrating (38%), remembering things (35%), and keeping dates straight (34%) The social/behavioral activities were more difficult in ≥30% of patients when experiencing fatigue. [21] Results of this study, also shows the same effect of fatigue on QOL. However, the study is limited by the fact that, fatigue was assessed in all cancer patients, regardless of primary site and type of the treatment.
Fatigue during Radiotherapy is unique as the treatment is protracted over many weeks and the patient needs to travel all the way everyday to receive the treatment. It is also associated with significant acute radiation accompaniments which alter the patient's nutrition, blood parameters leading to aggravation of the baseline fatigue. We have observed that the fatigue starts increasing from second week onwards and this coincides with the beginning of radiation reactions which settles at around four weeks after completion of radiation. Barbara et al., have shown that the fatigue increased during second week of radiation and decreased subsequently, probable explanation being the patient's ability to adapt to the treatment. [22] These authors have also observed that the radiotherapy free week ends were associated with a lesser fatigue. However we did not observe this in our study.
The quality of life parameters assessed such as the role function (routine work), emotional (irritability, tension and worry) and social function (social activities) showed a significant reduction during radiation but returned to normal at the end of one month of completion of radiotherapy. However the cognitive function (comprehension, memory) was affected only during the last week of radiation. Our interesting observation was that the financial difficulty was significant from the second week onwards and persisted at follow up also. This probably reflects the socioeconomic status of our patients and those from any developing country in general. Observations like these and from various other trials will probably help the healthcare givers in the developing countries to formulate and plan more cost effective treatment strategies and supportive care program.
Fatigue, like pain is a subjective symptom and hence varies from patient to patient and from time to time for any given patient, making it very difficult to assess its impact on quality of life. There are various questionnaires which are used to assess fatigue. Brief fatigue inventory scale is one among them. It has nine items on a ten point scale ranging from zero to ten. BFI is simple to use, easy to understand and is highly consistent. EORTC QLQ-C30 can be a useful instrument for the early detection of patients' impaired cognitive function and psychological morbidity. [23] The EORTC QLQ-C30 (version 3.0) is a 30-item cancer-specific core questionnaire that addresses various domains of QOL. It contains five function subscales (physical functioning, role functioning, emotional functioning, cognitive functioning and social functioning), three symptom subscales (fatigue, pain and nausea/vomiting), two single items assessing global health and 'overall' QOL and a number of single items addressing various symptoms and perceived financial impact. [24] Cancer related fatigue is present in majority of the patients at the start of treatment. Several clinical factors have been identified as causative elements in fatigue: pain, emotional distress, sleep disturbance, anemia, nutrition, activity level, and other co morbidities. These factors must be addressed in mitigating cancer-related fatigue. [25] It has been shown that exercise; including walking and aerobic exercise and resistance training, have beneficial effects on some symptoms related to cancer, including fatigue, distress, anxiety, and depressive symptoms. A recent systematic review indicates a trend toward improved physical functioning with exercise programs. An exercise prescription should take into account the patient's history and any physical constraints that may impact exercise safety and compliance. [21] There also is strong evidence that psychosocial interventions, including support groups, stress management, education, and behavioral intervention, are effective in treating fatigue in patients with cancer. [26] In our set of patients, it is our observation that explaining the details of treatment, associated treatment related morbidity before the beginning of radiation to the patient and the relatives takes care of the fatigue to a large extent. Weekly reassurance is also very important especially when they develop mucositis, radiation enteritis and other associated problems. Timely recognition and treatment of acute radiation accompaniments,
